Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-05-000009

Options or other derivatives

  • Director acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
EINSELEN PETER C Director 2005-01-03 Grant or award · Options +3,000 $6.00 $18,000 3,000 D: show line 1 in the form
Loading xslF345X02/primary_doc.xml…